Literature DB >> 10432382

Human mesangial cells express inducible macrophage scavenger receptor.

X Z Ruan1, Z Varghese, S H Powis, J F Moorhead.   

Abstract

BACKGROUND: Type A scavenger receptors (Scr) mediate the uptake of modified low-density lipoproteins by macrophages. The accumulation of lipids via this process is thought to lead to foam cell formation in atherosclerotic plaques. Human mesangial cells (HMCs) have not been previously shown to express Scr in normal culture. We therefore investigated whether there is an inducible form of Scr in a human mesangial cell line (HMCL).
METHODS: Scr activity was analyzed by cellular uptake of fluorescently labeled acetylated low-density lipoprotein using a flow cytometer. Scr mRNA expression was examined using reverse transcription-polymerase chain reaction, followed by Southern blotting. To investigate the molecular mechanism of Scr expression, several reporter gene constructs were designed. The first contained a full Scr promoter, the second a part of the Scr promoter that has both AP-1 and ets transcription factor binding sites. Other constructs were identical to the second, except that they contained either AP-1 or ets motif mutations.
RESULTS: Phorbol 12-Myristate 13-acetate (PMA) and angiotensin II (Ang II) increased both the percentage of Scr-positive cells and the Scr mean fluorescence intensity. PMA and Ang II also increased Scr mRNA and promoter activity in a time- and dose-responsive manner. Protein kinase C and calmodulin transduction pathways were involved in Scr up-regulation induced by PMA and Ang II. Additionally, a serine/threonine kinase was involved in PMA stimulation. Functional analysis showed that both AP-1 and ets motifs were specific response elements to PMA stimulation in HMCLs.
CONCLUSIONS: This study suggests that HMCs may express an inducible Scr, by which cells can acquire lipids and convert to foam cells in developing glomerulosclerosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10432382     DOI: 10.1046/j.1523-1755.1999.00587.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  16 in total

Review 1.  Dyslipidemia in patients with chronic and end-stage kidney disease.

Authors:  Jad Omran; Ashraf Al-Dadah; Kevin C Dellsperger
Journal:  Cardiorenal Med       Date:  2013-07-13       Impact factor: 2.041

Review 2.  Role of triglyceride-rich lipoproteins in diabetic nephropathy.

Authors:  John C Rutledge; Kit F Ng; Hnin H Aung; Dennis W Wilson
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

Review 3.  CD36 in chronic kidney disease: novel insights and therapeutic opportunities.

Authors:  Xiaochun Yang; Daryl M Okamura; Xifeng Lu; Yaxi Chen; John Moorhead; Zac Varghese; Xiong Z Ruan
Journal:  Nat Rev Nephrol       Date:  2017-09-18       Impact factor: 28.314

4.  Perindopril attenuates renal tubulointerstitium injury by inhibiting scavenger receptor A over-expression in diabetic rats.

Authors:  L Sun; J H Wen; H L Sun; X C Shu; F Hu; D C Yin; Q Yang; Y J Zeng; Y Sun; L Liu
Journal:  J Endocrinol Invest       Date:  2011-07-13       Impact factor: 4.256

5.  Inflammatory Stress Exacerbated Mesangial Foam Cell Formation and Renal Injury via Disrupting Cellular Cholesterol Homeostasis.

Authors:  Shan Zhong; Lei Zhao; Qing Li; Ping Yang; Zac Varghese; John F Moorhead; Yaxi Chen; Xiong Z Ruan
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

6.  High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease.

Authors:  Hyun Ju Kim; Nosratola D Vaziri; Keith Norris; Won Suk An; Yasmir Quiroz; Bernardo Rodriguez-Iturbe
Journal:  Clin Exp Nephrol       Date:  2010-09-07       Impact factor: 2.801

7.  Inhibitory Antibodies against PCSK9 Reduce Surface CD36 and Mitigate Diet-Induced Renal Lipotoxicity.

Authors:  Jae Hyun Byun; Paul F Lebeau; Khrystyna Platko; Rachel E Carlisle; Mahi Faiyaz; Jack Chen; Melissa E MacDonald; Yumna Makda; Tamana Yousof; Edward G Lynn; Jeffrey G Dickhout; Joan C Krepinsky; Fiona Weaver; Suleiman A Igdoura; Nabil G Seidah; Richard C Austin
Journal:  Kidney360       Date:  2022-04-27

Review 8.  An update on the lipid nephrotoxicity hypothesis.

Authors:  Xiong Z Ruan; Zac Varghese; John F Moorhead
Journal:  Nat Rev Nephrol       Date:  2009-10-27       Impact factor: 28.314

9.  Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA1, and HMG CoA reductase expression.

Authors:  Ali C M Johnson; Julie M Yabu; Sherry Hanson; Vallabh O Shah; Richard A Zager
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

10.  Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad.

Authors:  Mário Raimundo; José António Lopes
Journal:  Cardiol Res Pract       Date:  2011-02-20       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.